Angeliq Hormone Therapy Action Date Expected In Fourth Quarter
A late 2005 approval would come nearly four years after Schering AG filed the Angeliq NDA. Expected fourth quarter action date indicates company will submit CMC data by June.
A late 2005 approval would come nearly four years after Schering AG filed the Angeliq NDA. Expected fourth quarter action date indicates company will submit CMC data by June.